Impact of the 2020 China Diabetes Society Guideline on the Prevalence of Diabetes Mellitus and Eligibility for Antidiabetic Treatment in China

Nav

General Info

Geography

China (CHN)

Coverage type

Country

Time period covered

01/2011 - 12/2012

Data type

Scientific literature

Keywords

Diabetes

Citation

Authors

Shi G, Zhu N, Qiu L, Yan H, Zeng L, Wang D, Dang S, Li Z, Kang Y, Chen T, Li C

Journal

Int J Gen Med

Volume

Pages

6639-6645

Publication year

2021

Suggested citation

Shi G, Zhu N, Qiu L, Yan H, Zeng L, Wang D, Dang S, Li Z, Kang Y, Chen T, Li C. Impact of the 2020 China Diabetes Society Guideline on the Prevalence of Diabetes Mellitus and Eligibility for Antidiabetic Treatment in China. Int J Gen Med. 2021; 14: 6639-6645.

DOI

10.2147/IJGM.S331948

PMID

34675626

GHDx Entry last modified on: Apr 10, 2023

Header sites

Search form

Main menu

Impact of the 2020 China Diabetes Society Guideline on the Prevalence of Diabetes Mellitus and Eligibility for Antidiabetic Treatment in China

Nav